Betaine (trimethylglycine)
Also called: trimethylglycine, betaine anhydrous
Betaine, also called trimethylglycine, is found in beets, spinach and whole-grain breads; average daily intake is 100–300 mg. Betaine (betaine anhydrous) is a different ingredient from betaine hydrochloride, which has been sold as a stomach acidifier.
- Category
- Other
- Forms
- Betaine (betaine anhydrous), from Beta vulgaris root isolate or synthetic; Health Canada lists betaine hydrochloride as a separate medicinal ingredient
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2013 meta-analysis (Journal of Chiropractic Medicine) pooled 5 randomized placebo-controlled trials of daily betaine (at least 4 g/day, 6 to 24 weeks) in healthy adults. [3]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels1 topic
BMuscles and exercise1 topic
CImmune system and infection1 topic
XBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Plasma homocysteine in healthy adults | B | A 2013 meta-analysis of 5 RCTs (at least 4 g/day for 6 to 24 weeks) found betaine lowered plasma homocysteine by 1.23 μmol/L versus placebo. [3] |
| Muscular strength and power | B | A 2024 meta-analysis of 17 placebo-controlled studies (317 participants) found chronic betaine improved maximal strength (effect size 0.47), mainly lower body, but not upper-body strength, cycling sprint power or muscular endurance. [4] |
| Body weight and body composition | X | A 2022 meta-analysis found betaine did not significantly change body mass, BMI, body fat percentage, fat mass or fat-free mass compared with control. [5] |
| Inflammatory markers | C | A 2023 meta-analysis of 6 RCTs (277 participants) found a slight reduction in IL-1β with high heterogeneity and no significant change in CRP, IL-6 or TNF-α; the authors found insufficient evidence. [6] |
Main constituents: Betaine (trimethylglycine) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Homocysteine trials: at least 4 g/day of betaine for 6 to 24 weeks. [3]
- Exercise studies described by ODS: typically 2–5 g/day for up to 15 days. [1]
- The 2024 exercise meta-analysis included chronic supplementation of at least 7 days. [4]
Upper limits
- EU (EFSA, 2017): for betaine as a novel food, 400 mg/day (6 mg/kg body weight per day for adults) in addition to background dietary exposure is considered safe, derived from 4 g/day as a reference point with an uncertainty factor of 10. [7]
- EFSA (2019) found estimated intakes under revised proposed uses do not exceed that safe level and concluded betaine is safe under the new proposed conditions of use. [8]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox (Betaine, last update September 26, 2017): likelihood score E, unlikely cause of clinically apparent liver injury …
Details and sources - Pregnancy and breastfeedingHealth Canada's betaine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada NNHPD Betaine / Betaine hydrochloride monograph (January 30, 2026), adults 18 years and older: betaine 500 to 4,000 mg per day (liver …
Details and sources
- EFSA noted a significant increase in total and LDL cholesterol at 4 g/day of betaine in overweight subjects with metabolic syndrome, but not in healthy subjects, nor at 3 g/day. [7]
- LiverTox: likelihood score E (unlikely cause of clinically apparent liver injury); side effects are dose-related gastrointestinal effects such as diarrhea and nausea. With the drug in homocystinuria, rare but serious excessive increases in serum methionine may lead to life-threatening cerebral edema. [9]
- ODS states that research has not adequately evaluated the safety of betaine; several small studies of up to several weeks reported no side effects. [1]
- Health Canada requires cautions to ask a health care practitioner before use if pregnant or breastfeeding, and (at 600 mg/day or more of betaine) if you have high cholesterol. [2]
Identity, quality and standardization
- Health Canada lists betaine and betaine hydrochloride as separate medicinal ingredients with different uses and doses, and permits no combination of the two in one product. [2]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [11]
- US drug: LiverTox states betaine was approved as an orphan drug for use in homocystinuria in 1996 (brand name Cystadane; typical dose 3 to 10 grams twice daily). [9]
- US OTC drugs (betaine hydrochloride): 21 CFR 310.540 states that betaine hydrochloride has been present in OTC stomach acidifiers and that any OTC drug product offered for use as a stomach acidifier cannot be considered generally recognized as safe and effective. [10]
- EU: EFSA assessed betaine as a novel food in 2017 (Regulation (EC) No 258/97) and 2019 (Regulation (EU) 2015/2283). [8]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Betaine (common names betaine, betaine anhydrous, trimethylglycine) Amino acid derivative (trimethylglycine) [P7]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming betaine or trimethylglycine was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
- Betaine hydrochloride (a different ingredient): 21 CFR 310.540 states that any OTC drug product offered for use as a stomach acidifier cannot be considered generally recognized as safe and effective, and that such a product is regarded as a new drug requiring an approved new drug application. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of betaine was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). The IARC list's entry for arsenobetaine, an organic arsenic compound, concerns a different substance. [P3]
- The NTP Technical Reports index (TR-000 to TR-606) lists no study of betaine (checked 2026-10-29). [P4]
Liver (NIH LiverTox)
- LiverTox (Betaine, last update September 26, 2017): likelihood score E, unlikely cause of clinically apparent liver injury; doses of 6 to 20 grams daily have not been linked to hepatotoxicity. [P5]
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P6]
- Identity of the form: betaine (anhydrous) versus betaine hydrochloride — Health Canada lists them as separate medicinal ingredients with different uses and doses and permits no combination of the two. [P7]
Supply and conservation
- Health Canada lists betaine source material as Beta vulgaris root isolate or synthetic, and betaine hydrochloride as Beta vulgaris root isolate. [P7]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada NNHPD Betaine / Betaine hydrochloride monograph (January 30, 2026), adults 18 years and older: betaine 500 to 4,000 mg per day (liver function); betaine hydrochloride 180 to 3,500 mg per day (digestion), taken with a meal. [P7]
Pregnancy and breastfeeding
- Health Canada's betaine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [P7]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 310.540, Drug products containing active ingredients offered over-the-counter (OTC) for use as stomach acidifiers (version of 2026-10-23, retrieved via eCFR API), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports index (TR-000 to TR-606, checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Betaine (Last Update September 26, 2017), 2017-09-26. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Health Canada, NNHPD. Monograph: Betaine / Betaine hydrochloride (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
Sources
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
- Health Canada, NNHPD. Monograph: Betaine / Betaine hydrochloride (date 2026-01-30), 2026-01-30. webprod.hc-sc.gc.ca
- McRae MP. Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis. J Chiropr Med 2013;12(1):20-25 (PMID 23997720), 2013-03. pubmed.ncbi.nlm.nih.gov
- Zawieja E, et al. Effects of chronic betaine supplementation on exercise performance: systematic review and meta-analysis. J Sports Sci 2024;42(22):2131-2144 (PMID 39514262), 2024-11. pubmed.ncbi.nlm.nih.gov
- Ashtary-Larky D, et al. Betaine supplementation fails to improve body composition: a systematic review and meta-analysis. Br J Nutr 2022;128(5):975-988 (PMID 34743773), 2022-09-14. pubmed.ncbi.nlm.nih.gov
- Xu J, et al. Effects of betaine supplementation on inflammatory markers: a systematic review and meta-analysis of randomised controlled trials. Int J Food Sci Nutr 2023;74(7):721-729 (PMID 37733077), 2023-11. pubmed.ncbi.nlm.nih.gov
- EFSA NDA Panel. Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97. EFSA J 2017;15(11):e05057 (PMID 32625349), 2017-11-17. pubmed.ncbi.nlm.nih.gov
- EFSA NDA Panel. Safety of betaine as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J 2019;17(4):e05658, 2019-04-05. efsa.europa.eu
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Betaine (Last Update September 26, 2017), 2017-09-26. ncbi.nlm.nih.gov
- eCFR. 21 CFR 310.540, Drug products containing active ingredients offered over-the-counter (OTC) for use as stomach acidifiers (version of 2026-10-23, retrieved via eCFR API), 2026-10-23. ecfr.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Bromelain · Caffeine · Choline · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.